Rohan Dhillon, FRANZCP, MCLINSc

A patient nonadherent to oral medication is always a challenge. These clinicians wanted to move theirs to depot drug administration to ensure better compliance. Fortunately, they started with oral...

Dystonic reactions have not been commonly described with the second-generation antipsychotic lurasidone. Here, read the case of a patient with schizophrenia who developed episodes of recurrent oculogyric crises with...

The US Food and Drug Administration released a safety announcement regarding aripiprazole and the induction of impulse-control disorders. Read the case of a man with schizophrenia who experienced pathological...